- Home
- RVPHW vs IPG Comparison
RVPHW vs IPG Comparison
Compare RVPHW & IPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPHW
- IPG
- Stock Information
- Founded
- RVPHW 2018
- IPG 1902
- Country
- RVPHW United States
- IPG United States
- Employees
- RVPHW N/A
- IPG N/A
- Industry
- RVPHW Biotechnology: Pharmaceutical Preparations
- IPG Advertising
- Sector
- RVPHW Health Care
- IPG Consumer Discretionary
- Exchange
- RVPHW Nasdaq
- IPG Nasdaq
- Market Cap
- RVPHW N/A
- IPG 9.9B
- IPO Year
- RVPHW N/A
- IPG N/A
- Fundamental
- Price
- RVPHW $0.06
- IPG $26.20
- Analyst Decision
- RVPHW
- IPG Buy
- Analyst Count
- RVPHW 0
- IPG 8
- Target Price
- RVPHW N/A
- IPG $33.25
- AVG Volume (30 Days)
- RVPHW 22.4K
- IPG 7.3M
- Earning Date
- RVPHW 03-14-2025
- IPG 04-23-2025
- Dividend Yield
- RVPHW N/A
- IPG 5.01%
- EPS Growth
- RVPHW N/A
- IPG N/A
- EPS
- RVPHW N/A
- IPG 1.83
- Revenue
- RVPHW N/A
- IPG $9,187,600,000.00
- Revenue This Year
- RVPHW N/A
- IPG N/A
- Revenue Next Year
- RVPHW N/A
- IPG $2.69
- P/E Ratio
- RVPHW N/A
- IPG $14.92
- Revenue Growth
- RVPHW N/A
- IPG N/A
- 52 Week Low
- RVPHW $0.13
- IPG $26.15
- 52 Week High
- RVPHW $0.15
- IPG $35.17
- Technical
- Relative Strength Index (RSI)
- RVPHW N/A
- IPG 43.33
- Support Level
- RVPHW N/A
- IPG $26.22
- Resistance Level
- RVPHW N/A
- IPG $29.62
- Average True Range (ATR)
- RVPHW 0.00
- IPG 0.80
- MACD
- RVPHW 0.00
- IPG -0.02
- Stochastic Oscillator
- RVPHW 0.00
- IPG 16.14
About RVPHW Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.
About IPG Interpublic Group of Companies Inc. (The)
Interpublic Group is among the world's largest advertising holding companies based on annual revenue. It provides traditional advertising services along with digital and other services such as public relations through various acquisitions. IPG has made these services available in over 100 countries. The company generates about 65% of revenue in the US and 17% in the UK and Europe.